Do you want to read an article? Please log in or register.
Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial
Pulmonary Hypertension
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)